The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models
Open Access
Abstract
Background and Objectives: Ovarian tissue cryopreservation followed by autotransplantation (OTCTP) is currently the only fertility preservation option for prepubertal patients. Once in remission, the autotransplantation of frozen/thawed tissue is performed when patients want to conceive. A major issue of the procedure is follicular loss directly after grafting mainly due to follicle activation. To improve follicular survival during the OTCTP procedure, we inhibited the mTOR pathway involved in follicle activation using rapamycin, an mTOR inhibitor. Next, we compared two different in vivo models of transplantation: the recently described non-invasive heterotopic transplantation model between the skin layers of the ears, and the more conventional and invasive transplantation under the kidney capsule. Materials and Methods: To study the effects of adding rapamycin during cryopreservation, 4-week-old C57BL/6 mouse ovaries, either fresh, slow-frozen, or slow-frozen with rapamycin, were autotransplanted under the kidney capsule of mice and recovered three weeks later for immunohistochemical (IHC) analysis. To compare the ear with the kidney capsule transplantation model, fresh 4-week-old C57BL/6 mouse ovaries were autotransplanted to either site, followed by an injection of either LY294002, a PI3K inhibitor, vehicle control, or neither, and these were recovered three weeks later for IHC analysis. Results: Rapamycin counteracts cryopreservation-induced follicle proliferation, as well as AKT and mTOR pathway activation, in ovaries autotransplanted for three weeks under the kidney capsule of mice. Analyses of follicle proliferation, mTOR activation, and the effects of LY294002 treatment were similar in transplanted ovaries using either the ear or kidney capsule transplantation model. Conclusions: By adding rapamycin during the OTCTP procedure, we were able to transiently maintain primordial follicles in a quiescent state. This is a promising method for improving the longevity of the ovarian graft. Furthermore, both the ear and kidney capsule transplantation models were suitable for investigating follicle activation and proliferation and pharmacological strategies.Keywords
Funding Information
- Fonds de la Recherche Scientifique (F.R.S.-FNRS, Belgium) (7.6504.22, J.0156.20, J.0143.22, 2022-186)
- the Foundation Léon Fredericq (University of Liège) (7.6504.22, J.0156.20, J.0143.22, 2022-186)
This publication has 66 references indexed in Scilit:
- Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expressionGene, 2013
- Isoform 111 of Vascular Endothelial Growth Factor (VEGF111) Improves Angiogenesis of Ovarian Tissue XenotransplantationTransplantation, 2013
- Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cellsMolecular Cancer, 2012
- Impact of freezing and thawing of human ovarian tissue on follicular growth after long-term xenotransplantationJournal of Assisted Reproduction and Genetics, 2011
- Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathwaysMolecular Carcinogenesis, 2010
- Tissue culture before transplantation of frozen-thawed human fetal ovarian tissue into immunodeficient miceFertility and Sterility, 2010
- Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenograftingFertility and Sterility, 2009
- Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cellsJournal of Experimental & Clinical Cancer Research, 2008
- Methods for quantifying follicular numbers within the mouse ovaryReproduction, 2004
- The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cellsMutation Research/DNA Repair, 1995